The company, formerly Bansisons Tea Industries Limited, has successfully changed its name to Novyra Pharmachem Limited.

Bansisons Tea Industries Ltd519353 · Filed with the exchange

This change reflects a strategic expansion into the pharmaceutical, life sciences, and contract services sectors.

The company will now focus on manufacturing, processing, and global trading of active pharmaceutical ingredients (APIs), bulk drugs, intermediates, and specialty chemicals.

It also signifies an expanded focus on advanced research laboratories, eco-efficient green chemistry practices, and offering comprehensive contract research (CRO) and contract development and manufacturing (CDMO) services.

This move signals a significant pivot in the company's business strategy.

Read the original filing(PDF)

No comments yet. Be the first.

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

Create a free account

No card needed. Takes about a minute.

The company, formerly Bansisons Tea Industries Limited, has successfully changed its name to Novyra Pharmachem Limited.

More from Bansisons Tea Industries Ltd